Catherine Novack
Stock Analyst at Jones Trading
(3.08)
# 1,026
Out of 4,667 analysts
16
Total ratings
66.67%
Success rate
64.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Initiates: Buy | $130 | $50.52 | +157.31% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $17.98 | +122.47% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.72 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $14.40 | +11.11% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $6.16 | +127.46% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $3.21 | +305.62% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $1.41 | +467.38% | 1 | May 31, 2024 | |
| RZLT Rezolute | Initiates: Buy | $10 | $4.86 | +105.76% | 1 | Apr 18, 2024 | |
| FEMY Femasys | Maintains: Buy | $7 → $10 | $1.01 | +890.10% | 1 | Mar 20, 2024 | |
| CALC CalciMedica | Initiates: Buy | $22 | $3.46 | +535.84% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.58 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.52 | +6,249.21% | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.79 | +1,301.27% | 1 | Mar 10, 2023 |
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $50.52
Upside: +157.31%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $17.98
Upside: +122.47%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.72
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $14.40
Upside: +11.11%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $6.16
Upside: +127.46%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $3.21
Upside: +305.62%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.41
Upside: +467.38%
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.86
Upside: +105.76%
Femasys
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.01
Upside: +890.10%
CalciMedica
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.46
Upside: +535.84%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.58
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.52
Upside: +6,249.21%
Mar 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.79
Upside: +1,301.27%